Eric Baret

950 total citations
27 papers, 677 citations indexed

About

Eric Baret is a scholar working on Public Health, Environmental and Occupational Health, Pharmacology and Oncology. According to data from OpenAlex, Eric Baret has authored 27 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Public Health, Environmental and Occupational Health, 11 papers in Pharmacology and 7 papers in Oncology. Recurrent topics in Eric Baret's work include Malaria Research and Control (27 papers), Mosquito-borne diseases and control (11 papers) and Drug-Induced Hepatotoxicity and Protection (10 papers). Eric Baret is often cited by papers focused on Malaria Research and Control (27 papers), Mosquito-borne diseases and control (11 papers) and Drug-Induced Hepatotoxicity and Protection (10 papers). Eric Baret collaborates with scholars based in France, Senegal and Madagascar. Eric Baret's co-authors include Bruno Pradines, Christophe Rogier, Sébastien Briolant, Rémy Amalvict, Maud Henry, Joël Mosnier, Thierry Fusaı̈, Aurélie Pascual, Nathalie Wurtz and Yaya Diémé and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Eric Baret

27 papers receiving 665 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric Baret France	18	567	200	133	107	105	27	677
Mark Baker Switzerland	14	403 0.7×	155 0.8×	141 1.1×	131 1.2×	113 1.1×	22	757
Rémy Amalvict France	19	591 1.0×	246 1.2×	111 0.8×	134 1.3×	132 1.3×	41	849
Steven R. Meshnick United States	12	620 1.1×	212 1.1×	105 0.8×	78 0.7×	91 0.9×	17	861
Dominik Verdier-Pinard United States	5	732 1.3×	201 1.0×	151 1.1×	257 2.4×	145 1.4×	6	863
Sarah Arbe‐Barnes Switzerland	10	571 1.0×	251 1.3×	129 1.0×	60 0.6×	105 1.0×	16	880
Barbara Kotecka Australia	13	531 0.9×	167 0.8×	106 0.8×	98 0.9×	113 1.1×	32	844
M. T. Ekala France	7	469 0.8×	177 0.9×	81 0.6×	43 0.4×	68 0.6×	8	525
F. Joel Leong Singapore	9	334 0.6×	168 0.8×	54 0.4×	58 0.5×	93 0.9×	11	467
Pheaktra Chim Cambodia	9	911 1.6×	366 1.8×	114 0.9×	65 0.6×	78 0.7×	9	996
Ayo Oduola United States	5	475 0.8×	85 0.4×	124 0.9×	174 1.6×	85 0.8×	6	571

Countries citing papers authored by Eric Baret

Since Specialization

Citations

This map shows the geographic impact of Eric Baret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Baret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Baret more than expected).

Fields of papers citing papers by Eric Baret

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Baret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Baret. The network helps show where Eric Baret may publish in the future.

Co-authorship network of co-authors of Eric Baret

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Baret. A scholar is included among the top collaborators of Eric Baret based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Baret. Eric Baret is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dormoi, Jérôme, Hélène Savini, Rémy Amalvict, Eric Baret, & Bruno Pradines. (2014). In vitro interaction of lumefantrine and piperaquine by atorvastatin against Plasmodium falciparum. Malaria Journal. 13(1). 189–189. 7 indexed citations

Wurtz, Nathalie, Bécaye Fall, Aurélie Pascual, et al.. (2014). Role of Pfmdr1 in In Vitro Plasmodium falciparum Susceptibility to Chloroquine, Quinine, Monodesethylamodiaquine, Mefloquine, Lumefantrine, and Dihydroartemisinin. Antimicrobial Agents and Chemotherapy. 58(12). 7032–7040. 65 indexed citations

Fall, Bécaye, Aurélie Pascual, Fatoumata Diène Sarr, et al.. (2013). Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study. Malaria Journal. 12(1). 107–107. 22 indexed citations

Pascual, Aurélie, Bécaye Fall, Nathalie Wurtz, et al.. (2013). In vitro susceptibility to quinine and microsatellite variations of the Plasmodium falciparum Na+/H+ exchanger transporter (Pfnhe-1) gene in 393 isolates from Dakar, Senegal. Malaria Journal. 12(1). 189–189. 6 indexed citations

Briolant, Sébastien, Jérôme Dormoi, Joël Mosnier, et al.. (2012). Atorvastatin treatment is effective when used in combination with mefloquine in an experimental cerebral malaria murine model. Malaria Journal. 11(1). 13–13. 29 indexed citations

Briolant, Sébastien, Hervé Bogreau, Marine Gil, et al.. (2012). The F423Y Mutation in the pfmdr2 Gene and Mutations N51I, C59R, and S108N in the pfdhfr Gene Are Independently Associated with Pyrimethamine Resistance in Plasmodium falciparum Isolates. Antimicrobial Agents and Chemotherapy. 56(5). 2750–2752. 18 indexed citations

Wurtz, Nathalie, Bécaye Fall, Aurélie Pascual, et al.. (2012). Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal. Malaria Journal. 11(1). 197–197. 39 indexed citations

Gaillard, Tiphaine, B. Fall, Adama Tall, et al.. (2012). Absence of association between ex vivo susceptibility to doxycycline and pftetQ and pfmdt copy numbers in Plasmodium falciparum isolates from Dakar, Senegal. Clinical Microbiology and Infection. 18(7). E238–E240. 7 indexed citations

Andriantsoanirina, Valérie, Rémy Durand, Bruno Pradines, et al.. (2011). In vitro susceptibility to pyrimethamine of DHFR I164L single mutant Plasmodium falciparum. Malaria Journal. 10(1). 283–283. 15 indexed citations

10.

Pascual, Aurélie, Léonardo K. Basco, Eric Baret, et al.. (2011). Use of the atmospheric generators for capnophilic bacteria Genbag-CO2 for the evaluation of in vitro Plasmodium falciparum susceptibility to standard anti-malarial drugs. Malaria Journal. 10(1). 8–8. 22 indexed citations

11.

Fall, Bécaye, Eric Baret, Bakary Diatta, et al.. (2011). Ex vivo susceptibility of Plasmodium falciparum isolates from Dakar, Senegal, to seven standard anti-malarial drugs. Malaria Journal. 10(1). 310–310. 40 indexed citations

12.

Briolant, Sébastien, Stéphane Pelleau, Hervé Bogreau, et al.. (2011). In vitro susceptibility to quinine and microsatellite variations of the Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene: the absence of association in clinical isolates from the Republic of Congo. Malaria Journal. 10(1). 37–37. 23 indexed citations

13.

Pascual, Aurélie, Maud Henry, Sébastien Briolant, et al.. (2011). In Vitro Activity of Proveblue (Methylene Blue) on Plasmodium falciparum Strains Resistant to Standard Antimalarial Drugs. Antimicrobial Agents and Chemotherapy. 55(5). 2472–2474. 37 indexed citations

14.

Henry, Maud, Nathalie Wurtz, Jérôme Dormoi, et al.. (2010). Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum. Malaria Journal. 9(1). 139–139. 26 indexed citations

15.

Pradines, Bruno, Sébastien Briolant, Maud Henry, et al.. (2010). Absence of association between pyronaridine in vitro responses and polymorphisms in genes involved in quinoline resistance in Plasmodium falciparum. Malaria Journal. 9(1). 339–339. 19 indexed citations

16.

Wurtz, Nathalie, Marine Gil, Maud Henry, et al.. (2010). Synergy of mefloquine activity with atorvastatin, but not chloroquine and monodesethylamodiaquine, and association with the pfmdr1 gene. Journal of Antimicrobial Chemotherapy. 65(7). 1387–1394. 14 indexed citations

17.

Henry, Maud, Sandrine Alibert, Meïli Baragatti, et al.. (2008). Dihydroethanoanthracene Derivatives Reverse In Vitro Quinoline Resistance in Plasmodium falciparum Malaria. Medicinal Chemistry. 4(5). 426–437. 6 indexed citations

18.

Briolant, Sébastien, Philippe Parola, Thierry Fusaı̈, et al.. (2007). Influence of oxygen on asexual blood cycle and susceptibility of Plasmodium falciparum to chloroquine: requirement of a standardized in vitro assay. Malaria Journal. 6(1). 44–44. 30 indexed citations

19.

Pradines, Bruno, Eve Orlandi‐Pradines, Maud Henry, et al.. (2005). Métallocènes et paludisme : une nouvelle approche thérapeutique. Annales Pharmaceutiques Françaises. 63(4). 284–294. 4 indexed citations

20.

Millet, Julie, Sandrine Alibert, Christophe Rogier, et al.. (2004). Polymorphism in Plasmodium falciparum Drug Transporter Proteins and Reversal of In Vitro Chloroquine Resistance by a 9,10-Dihydroethanoanthracene Derivative. Antimicrobial Agents and Chemotherapy. 48(12). 4869–4872. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact